Ikena Oncology, Inc.IKNANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-2.3%
5Y CAGR+18.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-2.3%/yr
vs +66.4%/yr prior
5Y CAGR
+18.5%/yr
Recent deceleration
Acceleration
-68.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.73M | -12.5% |
| 2024 | $23.68M | -5.0% |
| 2023 | $24.93M | +12.3% |
| 2022 | $22.20M | +23.2% |
| 2021 | $18.02M | +103.2% |
| 2020 | $8.87M | +21.3% |
| 2019 | $7.31M | +152.1% |
| 2018 | $2.90M | - |